Clinical Trials Directory

Trials / Unknown

UnknownNCT04693442

Relationship Between Neutrophil Function and Sepsis in Adults and Children With Severe Thermal Injuries

A Multi-centre, Prospective Study to Examine the Relationship Between Neutrophil Function and Sepsis in Adults and Children With Severe Thermal Injuries

Status
Unknown
Phase
Study type
Observational
Enrollment
245 (estimated)
Sponsor
University Hospital Birmingham NHS Foundation Trust · Academic / Other
Sex
All
Age
1 Year – 99 Years
Healthy volunteers
Accepted

Summary

The study aims to validate neutrophil function, immature granulocyte and plasma free DNA levels as predictive diagnostic biomarkers of sepsis in burn patients. Inclusion criteria includes healthy volunteers, patients aged 5-15 years old with burns affecting 20% or less Total Body Surface Area (TBSA) and patients aged 16 or above with burns affecting \>15% TBSA. The study involves taking blood, tissue and urine samples.

Detailed description

The initial cohort for SIFTI-2 will be generated from patients attending the Birmingham Burns Centre at Queen Elizabeth Hospital Birmingham (QEHB) and Birmingham Children's Hospital (BCH). The cohort will be comprised of patients with moderate and severe burns (injury to more than 15% of the body surface area \[TBSA\] in adults and 20% TBSA in children). The investigators currently treat between 30-40 patients in this category each year. In order to thoroughly characterise the longitudinal neutrophil response to burn injury and to investigate its potential relationship with outcome post-burn, the ivestigators will measure the genomic, phenotypic and functional response of peripheral blood neutrophils across time in burn-injured patients.

Conditions

Interventions

TypeNameDescription
OTHERtaking of blood, urine and blood samples and objective scar assessmentblood, urine and skin tissue sampling \& scar assessment questionnaires

Timeline

Start date
2016-11-18
Primary completion
2022-01-31
Completion
2022-01-31
First posted
2021-01-05
Last updated
2021-01-05

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04693442. Inclusion in this directory is not an endorsement.